Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
University of Southern California
Maria Sklodowska-Curie National Research Institute of Oncology
Seattle Children's Hospital
Memorial Sloan Kettering Cancer Center
University of California, Irvine
Valo Therapeutics Oy
Memorial Sloan Kettering Cancer Center